Pfizer: Global Vaccine Distribution Transport Cases
Challenge
Pfizer needed temperature-controlled transport cases for global vaccine distribution including COVID-19, pneumococcal, RSV, and oncology biologics. Cases must: (1) maintain -70 C for mRNA vaccines, 2-8 C for traditional, (2) be WHO PQS + ISTA 7E qualified, (3) survive global air/sea/road transport, (4) integrate with Pfizer's SAP + Tracelink DSCSA, (5) be reusable 100+ cycles.
Solution
KeXinMaterials provided ultra-low PCM cases with: (1) VIP + dry ice compatible for -70 C (mRNA) or PCM for 2-8 C, (2) WHO PQS E001 + ISTA 7E qualified, (3) IP65 sealed, 120+ hours at target temp, (4) Bluetooth temperature logger + Tracelink DSCSA, (5) 100+ cycle rating. Custom foam for Pfizer-BioNTech, Comirnaty, Prevnar 20, Abrysvo, oncology biologics.
Result
5,500 cases deployed across 120 countries. 24 months zero temperature excursions. 100% DSCSA compliance. Pfizer standardized KeXinMaterials for all global vaccine/oncology transport. 5-year MSA in negotiation.
Client Testimonial
Pfizer's vaccine cold chain cannot tolerate temperature excursions. KeXinMaterials cases maintain -70 C for 120+ hours across 120 countries. The Tracelink DSCSA integration ensures full regulatory compliance. The 100+ cycle reusability supports our sustainability goals. They're now our global standard. — Pfizer Global Supply Chain VP
— Pfizer Inc.
Project Duration
Ongoing (5-year MSA)
Total Value
$5,200,000
Industry
Pharmaceutical / Vaccine
Related Resources
This case study demonstrates KeXinMaterials' ability to meet the most demanding requirements for the world's most demanding customers. The same engineering rigor applies across all our 45+ case studies. For similar projects, contact us at kexin@beeaa.com for a 12h custom quote.